Dec 7 (Reuters) – Generic drugmaker Mylan NV said on
Wednesday it may cut less than 10 percent of its global
workforce as part of a restructuring program.

The post UPDATE 1-EpiPen maker Mylan says may cut jobs appeared first on NASDAQ.